ANRO

Alto Neuroscience, Inc.NYSEHealthcare

$21.68-7.39%ClosedMarket Cap: $692.6M

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-04-02	Chardan Capital	—	Buy	—
2026-04-02	Baird	—	Outperform	—
2026-04-02	HC Wainwright & Co.	—	Buy	—
2026-04-02	Jones Trading	—	Buy	—
2026-04-02	Wedbush	—	Neutral	—
2026-02-17	BTIG	—	Buy	—
2026-01-05	Chardan Capital	—	Buy	—
2025-11-13	Baird	—	Outperform	—
2025-11-12	Jefferies	—	Buy	—
2025-10-24	HC Wainwright & Co.	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-2.88	$0.00	4
Sun Dec 31	$-2.88	$9.3M	6
Mon Dec 31	$-2.41	$49.0M	4
Tue Dec 31	$1.09	$294.5M	2